Levels of mineralocorticoids in whites and blacks

Hypertension

Volumn 34, Issue 2, 1999, Pages 315-319

  Pratt, J Howard ^a,b,d   Rebhun, John F ^a,b   Zhou, Lifen ^a   Ambrosius, Walter T ^a   Newman, Shirley A ^a   Gomez Sanchez, Celso E ^b   Mayes, Darrel F ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Endocrine Sciences   (United States)

^d Endocrine Sciences ^*  (United States)

Author keywords

18 hydroxycortisol; Aldosterone; Cortisol; Deoxycorticosterone; Race; Renin

Indexed keywords

18 HYDROXYHYDROCORTISONE; ALDOSTERONE; DEOXYCORTICOSTERONE; HYDROCORTISONE; MINERALOCORTICOID; TETRACOSACTIDE;

ADOLESCENT; ADULT; ARTICLE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPOTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; SODIUM ABSORPTION; SODIUM BALANCE; STEROIDOGENESIS;

EID: 0032878222     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.2.315     Document Type: Article

References (30)

1. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(suppl II):II-127-II-134.
2. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27(pt 2):481-490.
3. Channick BJ, Adlin EV, Marks AD. Suppressed plasma renin activity in hypertension. Arch Intern Med. 1969;123:131-140.
4. Brunner HR, Laragh JH, Baer L. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972;286:441-449.
5. Kaplan NM, Kem DC, Holland OB, Kramer NJ, Higgins J, Gomez-Sanchez C. The intravenous furosemide test: a simple way to evaluate renin responsiveness. Ann Intern Med. 1976;84:639-645.
6. National Health Survey. Blood Pressure of Adults by Race and Area -United States, 1960-1962. Hyattsville, Md: National Center for Health Statistics; 1964. Vital and Health Statistics, Series 1, No. 5.
7. National Health Survey. Blood Pressure of Persons 18-74 Years in the United States, 1971-1972. Hyattsville, Md: National Center for Health Statistics; 1975. Vital and Health Statistics, Series 2, No. 150.
8. Pratt JH, Manatunga AK, Bloem LJ, Wei L. Racial differences in aldosterone excretion: a longitudinal study in children. J Clin Endocrinol Metab. 1993;77:1512-1515.
9. Pratt JH, Jones JJ, Miller JZ, Wagner MA, Fineberg NS. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med. 1989;321:1152-1157.
10. Pratt JH, Dale SL, Gaunt R, Melby JC. Aldosterone secretion in the enucleated rat adrenal during salt retention. Endocrinology. 1998;95: 48-54.
11. Eberlin WR, Bongiovanni AM. Congenital adrenal hyperplasia with hypertension: unusual steroid pattern in blood and urine. J Clin Endocrinol Metabol. 1955;15:1531-1534.
12. Biglieri EG, Herron MA, Brust N. 17-Hydroxylation deficiency in man. J Clin Invest. 1966;45:1946-1954.
13. De Simone G, Tommaselli AP, Rossi R, Valentino R, Lauria R, Scopascasa F, Lombardi G. Partial deficiency of adrenal 11-hydroxylase: a possible cause of primary hypertension. Hypertension. 1985; 7:204-210.
14. Krozowski ZK, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci U S A. 1983;80:6056-6060.
15. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-comers approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992;10:473-482.
16. Litchfield WR, Hunt SC, Jeunemaitre X, Fisher NDL, Hopkins PN, Williams RR, Corvol P, Williams GH. Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension. Hypertension. 1998;31:569-574.
17. Gomez-Sanchez CE, Upcavage RJ, Zager PG, Foecking MF, Holland OB, Ganguly A. Urinary 18-hydroxycortisol and its relationship to the excretion of other adrenal steroids. J Clin Endocrinol Metab. 1987;65: 310-314.
18. Ulick S, Land M, Chu MD. 18-Oxocortisol, a naturally occurring mineralocorticoid agonist. Endocrinology. 1983;113:2320-2322.
19. Gomez-Sanchez CE, Gomez-Sanchez EP, Smith JE, Ferris MW, Foecking MF. Receptor binding and biological activity of 18-oxocortisol. Endocrinology. 1984;115:462-466.
20. Chu MD, Ulick S. Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism. J Biol Chem. 1982;257: 2218-2224.
21. Ulick S, Chu MD. Land M. Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue. J Biol Chem. 1983;258:5498-5502.
22. Gomez-Sanchez CE, Montgomery M, Ganguly A, Holland OB, Gomez-Sanchez EP, Grim CE, Weinberger MH. Elevated urinary excretion of 18-oxortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab. 1984;59:1022-1024.
23. Ulick S, Blumenfeld JD, Atlas SA, Wang JZ, Vaughan ED Jr. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 1993;76:873-878.
24. Manatunga AK, Jones JJ, Pratt JH. Longitudinal assessment of blood pressures in black and white children. Hypertension. 1993;22:84-89.
25. Gomez-Sanchez CE, Leon LM, Gomez-Sanchez EP. Biotin-hydrazide derivatives for the development of steroid enzyme-linked immunoassays. J Steroid Biochem Mol Biol. 1992;43:523-528.
26. Biglieri EG, Shamblean M, Slaton PEJ. Effects of adrenocorticotropin on desoxycorticosterone, corticosterone and aldosterone excretion. J Clin Endocrinol. 1969;29:1090-1101.
27. Bledsoe T, Island DP, Liddle GW. Studies of the mechanism through which sodium depletion increases aldosterone biosynthesis in man. J Clin Invest. 1966;45:524-530.
28. Sutherland DJA, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J. 1966;95:1109-1119.
29. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-295.
30. Gomez-Sanchez CE, Zager PG, Foecking MF, Holland OB, Ganguly A. 18-Oxocortisol: effect of dexamethasone, ACTH and sodium restriction. J Steroid Biochem. 1989;32:409-412.